Dycom Industries (NYSE: DY) reported earnings on Aug. 28. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended July 28 (Q4), Dycom Industries missed slightly on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue improved and GAAP earnings per share improved.

Margins shrank across the board.

Revenue details
Dycom Industries tallied revenue of $318.0 million. The seven analysts polled by S&P Capital IQ expected to see revenue of $323.5 million on the same basis. GAAP reported sales were 4.7% higher than the prior-year quarter's $303.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.39. The seven earnings estimates compiled by S&P Capital IQ predicted $0.41 per share. GAAP EPS of $0.39 for Q4 were 5.4% higher than the prior-year quarter's $0.37 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 20.7%, 60 basis points worse than the prior-year quarter. Operating margin was 7.2%, 20 basis points worse than the prior-year quarter. Net margin was 4.2%, 10 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $315.0 million. On the bottom line, the average EPS estimate is $0.45.

Next year's average estimate for revenue is $1.26 billion. The average EPS estimate is $1.41.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 118 members out of 124 rating the stock outperform, and six members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 31 give Dycom Industries a green thumbs-up, and one gives it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Dycom Industries is outperform, with an average price target of $28.50.